Time Interval Between TVT and First Void (TIBT) Study
Launched by GLOUCESTERSHIRE HOSPITALS NHS FOUNDATION TRUST · May 11, 2015
Trial Information
Current as of May 27, 2025
Unknown status
Keywords
ClinConnect Summary
Urinary incontinence is a global condition and its prevalence increases with age. It impairs quality of life of patients and has a significant burden on the health care system. Stress urinary incontinence (SUI) is defined as involuntary leakage of urine when there is an increase in pressure on the bladder, i.e. during exercise, coughing or sneezing. It is the commonest form of urinary incontinence and affects around 50% of women with symptoms of incontinence.
The development of mid urethral tapes (e.g. the tension free vaginal tape \[TVT\]) in 1998 has greatly changed clinical practice. Th...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Participant is willing and able to give informed consent for participation in the study
- Exclusion Criteria:
- • TVT performed under general or spinal anaesthetic
- • Women under the age of 18 years
- • Women unable to give informed consent
- • TVT performed in addition to another procedure
- • Women not suitable for a fluid challenge due to co-morbidities.
About Gloucestershire Hospitals Nhs Foundation Trust
Gloucestershire Hospitals NHS Foundation Trust is a leading healthcare organization in the UK, dedicated to providing high-quality patient care and advancing medical research. With a strong commitment to innovation and excellence, the Trust operates multiple hospitals and community services, facilitating a collaborative environment for clinical trials. By engaging in a diverse range of research initiatives, the Foundation Trust aims to enhance treatment options, improve patient outcomes, and contribute to the advancement of medical knowledge within the NHS framework. Their experienced clinical teams and robust infrastructure support the efficient execution of trials, ensuring the highest ethical standards and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Mark James, MBChB MD
Principal Investigator
Gloucestershire Hospitals NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials